42 related articles for article (PubMed ID: 16829753)
1. Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.
Massad LS; Xie X; Minkoff H; Kassaye S; Karim R; Darragh TM; Golub ET; Adimora A; Wingood G; Fischl M; Konkle-Parker D; Strickler HD
AIDS; 2020 Jan; 34(1):73-80. PubMed ID: 31789890
[TBL] [Abstract][Full Text] [Related]
2. Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
Mayeri DG; Kahasha PM; Kibalama IB; Mongane J; Louguè M; Birindwa EK; Mwimangire SC; Kikuru CK; Materanya JM; Bisimwa YK; Kasago B; Mukengeshai LM
Pan Afr Med J; 2024; 47():57. PubMed ID: 38646136
[TBL] [Abstract][Full Text] [Related]
3. Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
Alqabbani R; Chan J; Goldberg A
Am J Clin Pathol; 2024 Apr; 161(4):369-373. PubMed ID: 38035727
[TBL] [Abstract][Full Text] [Related]
4. Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.
Kim H; Kim KY; Kim D; Hwang JH
J Gynecol Oncol; 2024 May; 35(3):e26. PubMed ID: 38130135
[TBL] [Abstract][Full Text] [Related]
5. Factors related to inter-observer reproducibility of conventional Pap smear cytology: a multilevel analysis of smear and laboratory characteristics.
Baena A; Guevara E; Almonte M; Arias-Stella J; Sasieni P; Sanchez GI
Cytopathology; 2017 Jun; 28(3):192-202. PubMed ID: 28029192
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Anxiety Before and After Diagnostic Procedures in Women with Abnormal Papanicolaou Smear in Cervical Cancer Screening Program.
Ilic I; Babic G; Dimitrijevic A; Grujicic Sipetic S; Ilic M
Behav Med; 2024; 50(2):118-129. PubMed ID: 36268786
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
Ssedyabane F; Niyonzima N; Nambi Najjuma J; Birungi A; Atwine R; Tusubira D; Randall TC; Castro CM; Lee H; Ngonzi J
SAGE Open Med; 2024; 12():20503121241252265. PubMed ID: 38764539
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.
Makuza JD; Nsanzimana S; Muhimpundu MA; Pace LE; Ntaganira J; Riedel DJ
Pan Afr Med J; 2015; 22():26. PubMed ID: 26664527
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
Tirkaso BH; Bayisa TH; Desta TW
PLoS One; 2024; 19(4):e0301559. PubMed ID: 38635603
[TBL] [Abstract][Full Text] [Related]
10. Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature.
Colaci M; Giuggioli D; Cassone G; Vacchi C; Campomori F; Boselli F; Sebastiani M; Manfredi A; Ferri C
Int J Rheumatol; 2015; 2015():761867. PubMed ID: 26557142
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of the utility of endocervical curettage in screening population.
Song Y; Zhao YQ; Li L; Pan QJ; Li N; Zhao FH; Chen W; Zhang X; Qiao YL
Oncotarget; 2017 Jul; 8(30):50141-50147. PubMed ID: 28404931
[TBL] [Abstract][Full Text] [Related]
13. The use of endocervical curettage in women with low-grade squamous intraepithelial lesions or atypical squamous cells of unknown significance on Pap smear.
Miranda AD; Rodríguez R; Novoa DM; Rojas A; Pachón A; DiazGranados CA
J Low Genit Tract Dis; 2006 Jul; 10(3):146-50. PubMed ID: 16829753
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
15. Endocervical curettage in evaluating abnormal cervical cytology.
Moniak CW; Kutzner S; Adam E; Harden J; Kaufman RH
J Reprod Med; 2000 Apr; 45(4):285-92. PubMed ID: 10804483
[TBL] [Abstract][Full Text] [Related]
16. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
17. Endocervical curettage at the time of colposcopic assessment of the uterine cervix.
Abu J; Davies Q
Obstet Gynecol Surv; 2005 May; 60(5):315-20. PubMed ID: 15841025
[TBL] [Abstract][Full Text] [Related]
18. Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored.
Barreth D; Schepansky A; Capstick V; Johnson G; Steed H; Faught W
J Obstet Gynaecol Can; 2006 Dec; 28(12):1095-1098. PubMed ID: 17169233
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
